S, D., T, R., HJ, D., A, C., & SY, N. (2014). Rehabilitating drug-induced long-QT promoters: In-silico design of hERG-neutral cisapride analogues with retained pharmacological activity. BMC pharmacology & toxicology, 15, 14. https://doi.org/10.1186/2050-6511-15-14
Chicago Style (17th ed.) CitationS, Durdagi, Randall T, Duff HJ, Chamberlin A, and Noskov SY. "Rehabilitating Drug-induced Long-QT Promoters: In-silico Design of HERG-neutral Cisapride Analogues with Retained Pharmacological Activity." BMC Pharmacology & Toxicology 15 (2014): 14. https://doi.org/10.1186/2050-6511-15-14.
MLA (9th ed.) CitationS, Durdagi, et al. "Rehabilitating Drug-induced Long-QT Promoters: In-silico Design of HERG-neutral Cisapride Analogues with Retained Pharmacological Activity." BMC Pharmacology & Toxicology, vol. 15, 2014, p. 14, https://doi.org/10.1186/2050-6511-15-14.